Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Yeast Models of Phosphomannomutase 2 Deficiency, a Congenital Disorder of Glycosylation.

Lao JP, DiPrimio N, Prangley M, Sam FS, Mast JD, Perlstein EO.

G3 (Bethesda). 2019 Feb 7;9(2):413-423. doi: 10.1534/g3.118.200934.

2.

SPATIAL DISTRIBUTION OF ELECTRIC FIELD STRENGTH AT A TEACHING HOSPITAL PREMISES DUE TO TRANSMISSIONS BETWEEN 87.5 MHz AND 2.6 GHz.

Azah CK, Amoako JK, Sam F.

Radiat Prot Dosimetry. 2018 Aug 16. doi: 10.1093/rpd/ncy124. [Epub ahead of print]

PMID:
30125033
3.

Is Protein Kinase C Inhibition the Tip of the Iceberg in New Therapeutics for Acutely Decompensated Heart Failure?

Pimental DR, Sam F.

JACC Basic Transl Sci. 2017 Dec 25;2(6):684-687. doi: 10.1016/j.jacbts.2017.11.005. eCollection 2017 Dec. No abstract available.

4.

Reply: Diet-Induced Obesity HFpEF Murine Models.

Valero-Muñoz M, Sam F.

JACC Basic Transl Sci. 2018 Mar 1;3(1):158-159. doi: 10.1016/j.jacbts.2018.01.006. eCollection 2018 Feb. No abstract available.

5.

Cardiac macrophages promote diastolic dysfunction.

Hulsmans M, Sager HB, Roh JD, Valero-Muñoz M, Houstis NE, Iwamoto Y, Sun Y, Wilson RM, Wojtkiewicz G, Tricot B, Osborne MT, Hung J, Vinegoni C, Naxerova K, Sosnovik DE, Zile MR, Bradshaw AD, Liao R, Tawakol A, Weissleder R, Rosenzweig A, Swirski FK, Sam F, Nahrendorf M.

J Exp Med. 2018 Feb 5;215(2):423-440. doi: 10.1084/jem.20171274. Epub 2018 Jan 16.

6.

Murine Models of Heart Failure with Preserved Ejection Fraction: a "Fishing Expedition".

Valero-Muñoz M, Backman W, Sam F.

JACC Basic Transl Sci. 2017 Dec;2(6):770-789. doi: 10.1016/j.jacbts.2017.07.013. Epub 2017 Dec 25.

7.

Dual Endothelin-A/Endothelin-B Receptor Blockade and Cardiac Remodeling in Heart Failure With Preserved Ejection Fraction.

Valero-Munoz M, Li S, Wilson RM, Boldbaatar B, Iglarz M, Sam F.

Circ Heart Fail. 2016 Nov;9(11). pii: e003381.

8.

Follistatin like 1 Regulates Hypertrophy in Heart Failure with Preserved Ejection Fraction.

Tanaka K, Valero-Muñoz M, Wilson RM, Essick EE, Fowler CT, Nakamura K, van den Hoff M, Ouchi N, Sam F.

JACC Basic Transl Sci. 2016 Jun;1(4):207-221. doi: 10.1016/j.jacbts.2016.04.002. Epub 2016 Jun 27.

9.

A three dimensional micropatterned tumor model for breast cancer cell migration studies.

Peela N, Sam FS, Christenson W, Truong D, Watson AW, Mouneimne G, Ros R, Nikkhah M.

Biomaterials. 2016 Mar;81:72-83. doi: 10.1016/j.biomaterials.2015.11.039. Epub 2015 Dec 2.

PMID:
26724455
10.

Heart Failure With Preserved Ejection Fraction Induces Beiging in Adipose Tissue.

Valero-Muñoz M, Li S, Wilson RM, Hulsmans M, Aprahamian T, Fuster JJ, Nahrendorf M, Scherer PE, Sam F.

Circ Heart Fail. 2016 Jan;9(1):e002724. doi: 10.1161/CIRCHEARTFAILURE.115.002724.

11.

Heart Failure Resulting From Age-Related Cardiac Amyloid Disease Associated With Wild-Type Transthyretin: A Prospective, Observational Cohort Study.

Connors LH, Sam F, Skinner M, Salinaro F, Sun F, Ruberg FL, Berk JL, Seldin DC.

Circulation. 2016 Jan 19;133(3):282-90. doi: 10.1161/CIRCULATIONAHA.115.018852. Epub 2015 Dec 11.

12.

Monocyte and macrophage contributions to cardiac remodeling.

Hulsmans M, Sam F, Nahrendorf M.

J Mol Cell Cardiol. 2016 Apr;93:149-55. doi: 10.1016/j.yjmcc.2015.11.015. Epub 2015 Nov 21. Review.

13.

Transformative Impact of Proteomics on Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association.

Lindsey ML, Mayr M, Gomes AV, Delles C, Arrell DK, Murphy AM, Lange RA, Costello CE, Jin YF, Laskowitz DT, Sam F, Terzic A, Van Eyk J, Srinivas PR; American Heart Association Council on Functional Genomics and Translational Biology, Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular and Stroke Nursing, Council on Hypertension, and Stroke Council.

Circulation. 2015 Sep 1;132(9):852-72. doi: 10.1161/CIR.0000000000000226. Epub 2015 Jul 20. Review.

PMID:
26195497
14.

Withdrawal of heart failure medications in peripartum cardiomyopathy after myocardial recovery.

Tahir U, Sam F.

Int J Cardiol. 2015 Jul 1;190:212-3. doi: 10.1016/j.ijcard.2015.04.169. Epub 2015 Apr 22. No abstract available.

PMID:
25920029
15.

Delayed myocardial recovery in peripartum cardiomyopathy.

Tahir U, Doros G, Sam F.

Int J Cardiol. 2015 Apr 1;184:310-2. doi: 10.1016/j.ijcard.2015.02.064. Epub 2015 Feb 24. No abstract available.

PMID:
25731846
16.

Non-invasive imaging for cardiac amyloidosis - delaying the obvious?

Brogan A, Ding Y, Pimentel DR, Sam F.

Int J Cardiol. 2014 Dec 15;177(2):e87-9. No abstract available.

PMID:
25456697
17.

Effects of adiponectin on calcium-handling proteins in heart failure with preserved ejection fraction.

Tanaka K, Wilson RM, Essick EE, Duffen JL, Scherer PE, Ouchi N, Sam F.

Circ Heart Fail. 2014 Nov;7(6):976-85. doi: 10.1161/CIRCHEARTFAILURE.114.001279. Epub 2014 Aug 22.

18.

Hybrid metal grid-polymer-carbon nanotube electrodes for high luminance organic light emitting diodes.

Sam FL, Dabera GD, Lai KT, Mills CA, Rozanski LJ, Silva SR.

Nanotechnology. 2014 Aug 29;25(34):345202. doi: 10.1088/0957-4484/25/34/345202. Epub 2014 Aug 6.

PMID:
25100801
19.

Comparison of characteristics and outcomes of patients with heart failure preserved ejection fraction versus reduced left ventricular ejection fraction in an urban cohort.

Quiroz R, Doros G, Shaw P, Liang CS, Gauthier DF, Sam F.

Am J Cardiol. 2014 Feb 15;113(4):691-6. doi: 10.1016/j.amjcard.2013.11.014. Epub 2013 Nov 23.

PMID:
24484862
20.

Adiponectin modulates oxidative stress-induced autophagy in cardiomyocytes.

Essick EE, Wilson RM, Pimentel DR, Shimano M, Baid S, Ouchi N, Sam F.

PLoS One. 2013 Jul 19;8(7):e68697. doi: 10.1371/journal.pone.0068697. Print 2013.

21.

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines.

J Am Coll Cardiol. 2013 Oct 15;62(16):e147-239. doi: 10.1016/j.jacc.2013.05.019. Epub 2013 Jun 5. No abstract available.

22.

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

WRITING COMMITTEE MEMBERS, Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Circulation. 2013 Oct 15;128(16):e240-327. doi: 10.1161/CIR.0b013e31829e8776. Epub 2013 Jun 5. No abstract available.

PMID:
23741058
23.

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL.

Circulation. 2013 Oct 15;128(16):1810-52. doi: 10.1161/CIR.0b013e31829e8807. Epub 2013 Jun 5. No abstract available.

PMID:
23741057
24.

Mitochondrial encoded NADH dehydrogenase 5 (MT-ND5) gene point mutation presents as late onset cardiomyopathy.

Ayalon N, Flore LA, Christensen TG, Sam F.

Int J Cardiol. 2013 Sep 1;167(5):e143-5. doi: 10.1016/j.ijcard.2013.04.018. Epub 2013 Apr 28. No abstract available.

PMID:
23628297
25.

New and emerging biomarkers in left ventricular systolic dysfunction--insight into dilated cardiomyopathy.

Gopal DM, Sam F.

J Cardiovasc Transl Res. 2013 Aug;6(4):516-27. doi: 10.1007/s12265-013-9462-3. Epub 2013 Apr 23. Review.

26.

Circulating matrix metalloproteinases and tissue inhibitors of metalloproteinases in cardiac amyloidosis.

Tanaka K, Essick EE, Doros G, Tanriverdi K, Connors LH, Seldin DC, Sam F.

J Am Heart Assoc. 2013 Mar 12;2(2):e005868. doi: 10.1161/JAHA.112.005868.

27.

Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure.

Garcia AG, Wilson RM, Heo J, Murthy NR, Baid S, Ouchi N, Sam F.

Am J Physiol Heart Circ Physiol. 2012 Sep 1;303(5):H587-96. doi: 10.1152/ajpheart.00298.2012. Epub 2012 Jun 22.

28.

Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload.

Shimano M, Ouchi N, Nakamura K, van Wijk B, Ohashi K, Asaumi Y, Higuchi A, Pimentel DR, Sam F, Murohara T, van den Hoff MJ, Walsh K.

Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):E899-906. doi: 10.1073/pnas.1108559108. Epub 2011 Oct 10.

29.

Adiponectin in cardiovascular inflammation and obesity.

Aprahamian TR, Sam F.

Int J Inflam. 2011;2011:376909. doi: 10.4061/2011/376909. Epub 2011 Sep 15.

30.

Clinical features and survival in senile systemic amyloidosis: comparison to familial transthyretin cardiomyopathy.

Connors LH, Doros G, Sam F, Badiee A, Seldin DC, Skinner M.

Amyloid. 2011 Jun;18 Suppl 1:157-9. doi: 10.3109/13506129.2011.574354059. No abstract available. Erratum in: Amyloid. 2011 Jun;18 Suppl 1:159.

31.

High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution.

Seldin DC, Andrea N, Berenbaum I, Berk JL, Connors L, Dember LM, Doros G, Fennessey S, Finn K, Girnius S, Lerner A, Libbey C, Meier-Ewert HK, O'Connell R, O'Hara C, Quillen K, Ruberg FL, Sam F, Segal A, Shelton A, Skinner M, Sloan JM, Wiesman JF, Sanchorawala V.

Amyloid. 2011 Jun;18 Suppl 1:127-9. doi: 10.3109/13506129.2011.574354047. No abstract available. Erratum in: Amyloid. 2011 Jun;18 Suppl 1:129.

32.

Amyloidotic cardiomyopathy: multidisciplinary approach to diagnosis and treatment.

Seldin DC, Berk JL, Sam F, Sanchorawala V.

Heart Fail Clin. 2011 Jul;7(3):385-93. doi: 10.1016/j.hfc.2011.03.009. Epub 2011 May 20. Review.

33.

Cardiac hypertrophy and fibrosis in the metabolic syndrome: a role for aldosterone and the mineralocorticoid receptor.

Essick EE, Sam F.

Int J Hypertens. 2011;2011:346985. doi: 10.4061/2011/346985. Epub 2011 May 22.

34.

Office computer systems for the dental office.

Sam FE, Bonnick AM.

Dent Clin North Am. 2011 Jul;55(3):549-57, ix. doi: 10.1016/j.cden.2011.02.010.

PMID:
21726689
35.

Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling.

Essick EE, Ouchi N, Wilson RM, Ohashi K, Ghobrial J, Shibata R, Pimentel DR, Sam F.

Am J Physiol Heart Circ Physiol. 2011 Sep;301(3):H984-93. doi: 10.1152/ajpheart.00428.2011. Epub 2011 Jun 10.

36.

Follistatin-like 1 in chronic systolic heart failure: a marker of left ventricular remodeling.

El-Armouche A, Ouchi N, Tanaka K, Doros G, Wittköpper K, Schulze T, Eschenhagen T, Walsh K, Sam F.

Circ Heart Fail. 2011 Sep;4(5):621-7. doi: 10.1161/CIRCHEARTFAILURE.110.960625. Epub 2011 May 27.

37.

Cardiac myocyte-specific ablation of follistatin-like 3 attenuates stress-induced myocardial hypertrophy.

Shimano M, Ouchi N, Nakamura K, Oshima Y, Higuchi A, Pimentel DR, Panse KD, Lara-Pezzi E, Lee SJ, Sam F, Walsh K.

J Biol Chem. 2011 Mar 18;286(11):9840-8. doi: 10.1074/jbc.M110.197079. Epub 2011 Jan 18.

38.

Evidence for a functional role of the molecular chaperone clusterin in amyloidotic cardiomyopathy.

Greene MJ, Sam F, Soo Hoo PT, Patel RS, Seldin DC, Connors LH.

Am J Pathol. 2011 Jan;178(1):61-8. doi: 10.1016/j.ajpath.2010.11.015. Epub 2010 Dec 23.

39.

Oxidative stress and autophagy in cardiac disease, neurological disorders, aging and cancer.

Essick EE, Sam F.

Oxid Med Cell Longev. 2010 May-Jun;3(3):168-77. doi: 10.4161/oxim.3.3.12106. Review.

40.

State hospitals, academic medicine and the decline of health care in South Africa - a cry of support from those who have left for those who stay.

Don-Wauchope AC, Karas A, Chetty VT, Davidson HK, Gottschalk R, Rabiner EA, Sam F, Sommerville GP, Swartz J, Viljoen A.

S Afr Med J. 2010 Jan 29;100(2):74-5. No abstract available.

PMID:
20459900
41.

Serial troponin-I measurement as a diagnostic and therapeutic tool in chronic myocarditis.

Quiroz R, Joseph L, Sam F.

J Heart Lung Transplant. 2010 Jul;29(7):820-2. doi: 10.1016/j.healun.2010.03.006. Epub 2010 Apr 22. No abstract available.

42.

Determinants of adiponectin levels in patients with chronic systolic heart failure.

Biolo A, Shibata R, Ouchi N, Kihara S, Sonoda M, Walsh K, Sam F.

Am J Cardiol. 2010 Apr 15;105(8):1147-52. doi: 10.1016/j.amjcard.2009.12.015. Epub 2010 Feb 20.

43.

Cutaneous sinus tracts (or emerging sinus tracts) of odontogenic origin: a report of 3 cases.

Brown RS, Jones R, Feimster T, Sam FE.

Clin Cosmet Investig Dent. 2010 Jul 5;2:63-7. Print 2010.

44.

What can adiponectin say about left ventricular function?

Sam F, Walsh K.

Heart. 2010 Mar;96(5):331-2. doi: 10.1136/hrt.2009.178590. Epub 2009 Nov 23. No abstract available.

45.

Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure.

Sam F, Duhaney TA, Sato K, Wilson RM, Ohashi K, Sono-Romanelli S, Higuchi A, De Silva DS, Qin F, Walsh K, Ouchi N.

Endocrinology. 2010 Jan;151(1):322-31. doi: 10.1210/en.2009-0806. Epub 2009 Oct 22.

46.

Cardiac-specific deletion of LKB1 leads to hypertrophy and dysfunction.

Ikeda Y, Sato K, Pimentel DR, Sam F, Shaw RJ, Dyck JR, Walsh K.

J Biol Chem. 2009 Dec 18;284(51):35839-49. doi: 10.1074/jbc.M109.057273.

47.

Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition.

Biolo A, Ramamurthy S, Connors LH, O'Hara CJ, Meier-Ewert HK, Soo Hoo PT, Sawyer DB, Seldin DC, Sam F.

Circ Heart Fail. 2008 Nov;1(4):249-57. doi: 10.1161/CIRCHEARTFAILURE.108.788687. Epub 2008 Oct 14. Erratum in: Circ Heart Fail. 2009 May;2(3):e3. Seldin, David S [corrected to Seldin, David C].

48.

Effects of fixed-dose isosorbide dinitrate/hydralazine on diastolic function and exercise capacity in hypertension-induced diastolic heart failure.

Wilson RM, De Silva DS, Sato K, Izumiya Y, Sam F.

Hypertension. 2009 Sep;54(3):583-90. doi: 10.1161/HYPERTENSIONAHA.109.134932. Epub 2009 Jul 20.

PMID:
19620510
49.

Fenofibrate inhibits aldosterone-induced apoptosis in adult rat ventricular myocytes via stress-activated kinase-dependent mechanisms.

De Silva DS, Wilson RM, Hutchinson C, Ip PC, Garcia AG, Lancel S, Ito M, Pimentel DR, Sam F.

Am J Physiol Heart Circ Physiol. 2009 Jun;296(6):H1983-93. doi: 10.1152/ajpheart.00002.2009. Epub 2009 Apr 24.

50.

A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failure.

Jain M, Jakubowski A, Cui L, Shi J, Su L, Bauer M, Guan J, Lim CC, Naito Y, Thompson JS, Sam F, Ambrose C, Parr M, Crowell T, Lincecum JM, Wang MZ, Hsu YM, Zheng TS, Michaelson JS, Liao R, Burkly LC.

Circulation. 2009 Apr 21;119(15):2058-68. doi: 10.1161/CIRCULATIONAHA.108.837286. Epub 2009 Apr 6.

Supplemental Content

Support Center